669 related articles for article (PubMed ID: 27167350)
1. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
[TBL] [Abstract][Full Text] [Related]
3. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
[TBL] [Abstract][Full Text] [Related]
4. Oligoclonal selection of nanobodies targeting vascular endothelial growth factor.
Ahadi M; Ghasemian H; Behdani M; Kazemi-Lomedasht F
J Immunotoxicol; 2019 Dec; 16(1):34-42. PubMed ID: 30409071
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody.
Kazemi-Lomedasht F; Behdani M; Bagheri KP; Habibi-Anbouhi M; Abolhassani M; Arezumand R; Shahbazzadeh D; Mirzahoseini H
Mol Immunol; 2015 May; 65(1):58-67. PubMed ID: 25645505
[TBL] [Abstract][Full Text] [Related]
6. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
Xia X; M M; Zhai T; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
[TBL] [Abstract][Full Text] [Related]
8. Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF.
Ebrahimizadeh W; Mousavi Gargari SL; Javidan Z; Rajabibazl M
Appl Biochem Biotechnol; 2015 Aug; 176(7):1985-95. PubMed ID: 26054617
[TBL] [Abstract][Full Text] [Related]
9. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
[TBL] [Abstract][Full Text] [Related]
10. A novel nanobody against urease activity of Helicobacter pylori.
Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
[TBL] [Abstract][Full Text] [Related]
11. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
[TBL] [Abstract][Full Text] [Related]
13. Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus.
Ji P; Zhu J; Li X; Fan W; Liu Q; Wang K; Zhao J; Sun Y; Liu B; Zhou EM; Zhao Q
J Nanobiotechnology; 2020 Mar; 18(1):44. PubMed ID: 32169061
[TBL] [Abstract][Full Text] [Related]
14. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
[TBL] [Abstract][Full Text] [Related]
15. Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells.
Zare H; Rajabibazl M; Rasooli I; Ebrahimizadeh W; Bakherad H; Ardakani LS; Gargari SL
Int J Biol Markers; 2014 Jun; 29(2):e169-79. PubMed ID: 24425321
[TBL] [Abstract][Full Text] [Related]
16. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
[TBL] [Abstract][Full Text] [Related]
17. Production of a novel camel single-domain antibody specific for the type III mutant EGFR.
Omidfar K; Rasaee MJ; Modjtahedi H; Forouzandeh M; Taghikhani M; Golmakani N
Tumour Biol; 2004; 25(5-6):296-305. PubMed ID: 15627895
[TBL] [Abstract][Full Text] [Related]
18. Rapid and Sensitive Detection of Staphylococcal Enterotoxin B by Recombinant Nanobody Using Phage Display Technology.
Zanganeh S; Rouhani Nejad H; Mehrabadi JF; Hosseini R; Shahi B; Tavassoli Z; Aramvash A
Appl Biochem Biotechnol; 2019 Feb; 187(2):493-505. PubMed ID: 29984392
[TBL] [Abstract][Full Text] [Related]
19. Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody.
Darvish M; Behdani M; Shokrgozar MA; Pooshang-Bagheri K; Shahbazzadeh D
Mol Immunol; 2015 Dec; 68(2 Pt B):412-20. PubMed ID: 26468036
[TBL] [Abstract][Full Text] [Related]
20. A camel anti-lysozyme CDR3 only domain antibody selected from phage display VHH library acts as potent lysozyme inhibitor.
Qiu L; Feng Y; Ma X; Li J
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):513-519. PubMed ID: 28475681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
